Abiopharma

🔍 Gallagher Thomas P. (Director)

Company: MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 150,300 shares of Common Stock at $42.41 per share (Direct)
  Date: 2026-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,572,975.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 149,700 shares of Common Stock at $41.13 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,423,275.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2

Footnotes:

• F1: Represents shares that have been surrendered to the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of restricted stock awards and does not represent a sale by the reporting person.
• F2: Mr. Gallagher maintains beneficial ownership, including dispositive and voting control, over Gallagher Investments, LLC.
• F3: This transaction was effected pursuant to a previously established Rule 10b5-1 Plan adopted by the Reporting Person on December 29, 2025.
• F4: This transaction was executed in multiple trades throughout the day at prices ranging from $38.85 to $42.56. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.